ArticleDiscover oncology2025

RBIS as a prognostic biomarker for progression-free survival in prostate cancer: insights from bioinformatics and immune infiltration analysis.

Zexiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.